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ABSTRACT 
Meclizine Hydrochloride is an Anti-Histamine drugs with very low bioavailability that can be improved by increasing its solubility and 
dissolution rate. The aim of this study is to enhance dissolution of Meclizine Hydrochloride as a model hydrophobic drug through application of 
inclusion complex technology. It was formulated as inclusion complex compact, and its dissolution property is evaluated and c ompared with 
marketed product of Meclizine Hcl tablet. The newly formulated drug and the interaction between excipients was examined by, Fourier-
transform infrared spectroscopy, and differential scanning colorimetry, respectively. Both DSC and SEM results suggested loss of crystallinity of 
Meclizine Hydrochloride upon conversion into a inclusion complex formulation. The dissolution efficiency of Meclizine Hydrochloride at 45 min 
was increased from directly compressed tablet to 98.0% for marketed product to 97.2% at 45 minutes for the inclusion complex formulation. 
The increase in the dissolution rate was also found to be significant compared to the marketed product. The inclusion complex technique 
appears to be a promising approach for improving the dissolution of poorly soluble drugs like Meclizine Hydrochloride.  
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1.0 INTRODUCTION 
Cyclodextrins (CD) inclusion complexation, which is the 
arrangement of host–guest inclusion complexes by weak 
intermolecular interaction, has been shown to be a 
promising technique in enhancing solubility and 
bioavailability of poorly BCS class II drugs. The molecular 
structure of cyclodextrins appears to be a truncated cone, 
arries a hydrophilic exterior surface and a non-polar interior 
cavity. The central cavity of the cyclodextrins molecule is 
lined with skeletal carbons and ethereal oxygens of the 
glucose residues. It provides a Lipophilic microenvironment 
into which suitably sized API drug molecules may enter and 
be included. This method has been shown to improve the 
solubility of various drugs such as celecoxib and natamycin 
etc. The commonly available cyclodextrins are, α-, β- and γ-
cyclodextrins, which consist of 6, 7 and 8 glucopyranose 
units, respectively. β-Cyclodextrins (β CD) and their 
derivatives, such as hydroxypropyl-βCD (HPβCD) and 
methyl βCD (MβCD), are the main excipients commonly used 
in pharmaceutical formulations. In general, chemical 
modification of CDs can alter their physical properties, 
especially their solubility. The solubility of βCD in water is 
relatively low (approximately 18.5 mg/mL at 25 °C), 
whereas it’s derivative HP βCD has a higher aqueous 
solubility (approx. 600 mg/mL at 25 °C). There are different 
methods to prepare cyclodextrins inclusion complexes. 
These methods encompass co-precipitation, kneading, 
lyophilization, spray drying, freeze drying and supercritical 
fluid technology. Meclizine Hydrochloride is an Anti 
Histamine drugs. It is used mainly in the treatment of motion 
sickness and vertigo. The poor solubility of Meclizine 
Hydrochloride reduces the bioavailability to around 30 to 
40%. Figure. 1 shows the chemical structures of Meclizine 
Hydrochloride and βCD. In the present study, solubility and 
dissolution enhancement of β-cyclodextrins (βCD) on 
Meclizine Hydrochloride was compared. Inclusion complex 
was prepared using three different methods, namely, 
physical mixture, kneading and Co-precipitate method. The 
inclusion complex was characterised using scanning electron 
microscopy, infrared spectrophotometer, powder X-ray 
diffractometry, and differential scanning calorimetry. 
 
Sharma et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2019; 9(4):57-64 
ISSN: 2250-1177                                                                                  [58]                                                                                 CODEN (USA): JDDTAO 
                                                             
(A)                                                                                   (B) 
Fig. 1 - Chemical structures of (A) Meclizine HCl  (B) βCD 
2.0 
MATERIALS AND METHODS 
Materials: Meclizine Hydrochloride was a gift sample 
from Srikem Labatories Limited Mumbai. Other materials 
were purchased from different sources like β Cyclodextrins  
from Gangwal chemicals Mumbai Lactose and Talc from 
signet chemicals, Mumbai, Micro crystalline cellulose  PH 
102  and crosspovidone and ethanol from SR Chemi Mumbai 
India  and all other reagents used were of analytical grade 
and obtained from S.D. Fine Chemicals, Mumbai, India. 
Doubled distilled water was used during entire research 
work. 
Phase Solubility Studies: 6,7,8 
The phase-solubility technique permits the evaluation of the 
affinity between β-CD and Meclizine HCl in water. It gives 
not only the solubilising ability of CD's, but also the stability 
constant of the complexes by analyzing the solubility curve. 
Phase solubility studies were performed according to the 
method reported by Higuchi and Connors. This methodology 
was based on the solubility variation of the guest molecule 
(drug) upon increase of the host molecule (β-CD/) 
concentration. For phase solubility studies of Meclizine 
Hydrochloride, an excess of drug (200 mg) was added to 20 
ml portions of distilled water, each containing variable 
amount of β-cyclodextrin such as 2, 4, 6, 8, and 10 m Moles. 
All the above solutions with variable amount of β-
cyclodextrins were shaken for 72 hours. After shaking, 
approximately 0.5 ml of the solution was withdrawn by the 
syringe and filtered through a 0.22 μm membrane filter 
(Millipore) and suitably diluted with water. Drug 
concentration was determined spectrophotometrically using 
(UV-1240, Shimadzu, Japan) at 230 nm. The phase solubility 
plot was prepared by plotting the total dissolved drug 
concentration against the total β Cyclodextrin 
concentrations separately. The apparent complexation 
constant (K1:3) of the complex was calculated by the 
following equation (Eq. 1) from phase solubility curve, 
where the intercept is the intrinsic solubility of drug in the 
absence of polymer. 
                                            
K1:3 =       Slope          Eq. ------- (1)  
                         Intercept (1-slope)    
 
 
Preparation of complexes with β-cyclodextrin: 9,10,11  
Complexes of Meclizine Hydrochloride with β-cyclodextrin 
(β-CD) were prepared by different methods using different 
molar concentrations of β-CD. The molar concentration used 
and methods adopted are mentioned below. 
a) Physical mixture: Meclizine Hydrochloride with β-CD 
in different molar ratios (i.e. 1:1M, 1:2M and 1:3M) were 
mixed in a mortar for about 30 minutes with constant 
trituration, passed through sieve No. 60 and stored in a 
desiccators over fused calcium chloride. 
b) Kneading method: Meclizine Hydrochloride with β-
CD in different molar ratios (i.e. 1:1M, 1:2M and 1:3M) was 
taken. First cyclodextrin is added to the mortar, small 
quantity of 50 % ethanol is added while triturating to get 
slurry like consistency. Then slowly Meclizine Hydrochloride 
is incorporated into the slurry and trituration is further 
continued for 30 minutes. Slurry is then air dried at 25OC for 
4 hours, pulverized and passed through sieve No. 60 and 
stored in desiccators over fused calcium chloride. 
c) Co-precipitate method: Meclizine Hydrochloride was 
dissolved in ethanol at room temperature and β-CD was 
dissolved in distilled water. Different molar ratios (i.e. 1:1M 
1:2M and 1:3M of Meclizine Hydrochloride and β-CD were 
taken respectively. The mixture was stirred at room 
temperature, for 30 minutes and then slowly evaporated on 
a boiling water bath. The inclusion complex precipitated as a 
crystalline powder was pulverized and passed through sieve 
No. 60 and stored in a desiccator till free from any traces of 
the organic solvent. 
Sifted material Mix with other Prelubricant material and for 
10 minutes and then add Magnesium Stearate and mix for 2 
minutes. 
Differential Scanning Calorimetry (DSC) 12 
DSC analysis was performed using a DSC 822e with a robotic 
sampler from Mettler Toledo and thermal characteristics of 
the drug and solid dispersions were determined. The 
instrument was calibrated using indium as the standard. 
Approximately 5 mg of each sample was placed in 100 µL 
aluminum pans which were sealed and initial and final 
temperature were set and heated from 25°C to 300°C at a 
rate of 10°C/min under nitrogen flow of 30 ml/min. 
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Scanning electron microscopy 
The surface morphology of the Meclizine Hydrochloride and 
inclusion complex was determined using scanning electron 
microscopy (LEO 435 VARIABLE PRESSURE SEM), operated 
at an accelerating voltage of 20 kV (beam current of 30–40 
mA, filament current of 1.75 lA, and probe current of 250 
pA) Robinson detector and at magnification ranging from 
minimum magnification-4x and maximum magnification of 
5000x. 
Fourier transform infrared spectroscopy 12,13 
Fourier transform IR spectra were recorded on FT/IR-8400 
S Shimadzu. The spectra were recorded for Meclizine HCl 
and inclusion complex system. Samples were prepared in a 
KBr disc (3mg of the sample in 300mg KBr). The pinch of the 
powder sample was inserted in the sample holder and the 
spectra were run from 3800 cm-1 to 650 cm-1. 
In vitro dissolution studies 13 
The dissolution patterns of the inclusion complexes were 
compared with those of a market product. The dissolution 
studies were performed according to the USP XXIII 
Dissolution apparatus (ELECTROLAB TDL-08L), Type-I 
(Basket). The dissolution medium was 900 ml of 0.01N HCl 
(pH 1.2). The stirring speed of the basket was 100 rpm, and 
the temperature was maintained at 37 ± 0.5°C. The samples 
(5 ml) were withdrawn at various time intervals, which was 
filtered through a 0.45 μm membrane filter and analyzed by 
a HPLC spectrophotometer at 230 nm. 
Formulation of tablets by direct compression method 9, 
10, 11 
Tablet compacts were prepared using a Fluid pack 10 ton 
laboratory press 10.5 x 5.49 mm, Oval shaped Embossed 
Tooling (Upper punches: Embossed with “ET3”, Lower 
punches: plain). Tablets weighing 360 mg ± 5% were 
compressed to 2 kN for 3 seconds and ejected from the die. 
 
Table 1: Batches of Meclizine Hydrochloride Tablets by Inclusion Complex. 
 
S.No 
 
Ingredients  
CD1 
(mg) 
CD2 
(mg) 
CD3 
(mg) 
CD4 
(mg) 
CD5 
(mg) 
CD6 
(mg) 
CD7 
(mg) 
CD8 
(mg) 
CD9 
(mg) 
Intra Granular Materials     
Complex Ratio 1:1 1:2 1:3 1:1 1:2 1:3 1:1 1:2 1:3 
1 Meclizine 
Hydrochloride 
25.0 25.0 25.0 25.0 25.0 25.0 25.0 25.0 25.0 
2 β Cyclodextrins 58.8 117.6 176.4 58.8 117.6 176.4 117.6 176.4 58.8 
3 Ethanol Q.s Q.s Q.s Q.s Q.s Q.s Q.s Q.s Q.s 
4 Lactose  regular 136.1 77.3 18.5 136.1 77.3 18.5 77.3 18.5 136.1 
5 Microcrystalline 
Cellulose PH 102 
114.0 114.0 114.0 114.0 114.0 114.0 114.0 114.0 114.0 
6 Crospovidone 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 
7 Talc  3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Lubrication          
8 Magnesium 
Sterate 
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Weight of core tablet  360.0 360.0 360.0 360.0 360.0 360.0 360.0 360.0 360.0 
 
Micromeritic properties of blend 12, 13, 14, 15, 16, 17, 
The flow properties of powder plays vital role in the 
manufacturing of tablets. The flow properties were studied 
through measuring the angle of repose, Carr’s index. Powder 
mixtures of different formulations were evaluated for angle 
of repose, bulk density, tapped density Hausner’s Ratio and 
compressibility index. It is usually determined by the fixed 
funnel method and is the measure of the flow ability of 
powder/granules. A funnel with 10 mm inner diameter of 
the stem was fixed at a height of 2 cm. Over the platform. 
About 10 mg of sample was slowly passed along the wall of 
the funnel till the tip of the pile formed and touches the stem 
of the funnel. A rough circle was drawn around the pile base 
and the radius of the powder cone was measured. Angle of 
repose was calculated from the average radius, using the 
following formula. 
Ө = Tan- [h/r] Eq. ------- (2) 
In which, θ is the angle of repose, h is the height of the cone 
and r is radius of base. To measure the angle of repose 
The bulk density (δb) of a powder was determined by 
measuring the volume of a known mass of powder sample 
into a 100 ml graduated cylinder. Tapped density (δtap) of 
powder samples were determined by a tap density 
apparatus. Tap the cylinder 10, 500 and 1250 taps on the 
same powder sample and read the corresponding volume 
V10, V500 and V1250 to the nearest graduated unit. The Carr’s 
Index is a measure of the propensity of a powder to be 
compressed and it is calculated using the following formula:  
Carr’s Index = [(δtap -δb) / δtap] / ×100        Eq. ------- (3) 
Evaluation of post compression parameters of tablets 
The prepared tablets were evaluated for tablet hardness 
using a Monsanto Tablet tester, friability of a sample of 6.5 g 
tablets was measured using a Roche Friabilator (Electro lab), 
the weight variation test was done by weighing 20 tablets 
(USP) individually and calculating the average weight with 
comparing the individual tablet weight to the average 
weight, disintegration time of the tablet was measured in 
water (37±2°C) according to the disintegration test 
apparatus with a disk (Electro lab).  
3.0 RESULTS 
Phase solubility study 
The solubility method is useful for studying inclusion 
compounds for poorly soluble drugs with CDs in water 
because it gives not only the solubilizing ability of CDs but 
also the stability constant (Ks) of the complexes by analyzing 
the solubility curves. 
The phase solubility curves of Meclizine Hydrochloride in the 
presence of ß-CD are presented in Figure.2. This curve 
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indicated a linear increase in solubility of Meclizine 
Hydrochloride with increase in concentrations of β-CD in 
water. Increasing amounts of β-CD increased the aqueous 
solubility of Meclizine Hydrochloride. 
The shape of solubility diagram represents linear host–guest 
correlation (AL Type) with a slope less than 1 indicating the 
formation of a 1:2 complex with respect to β-CD 
concentrations. It was observed that the Meclizine HCl/β-CD 
system shows greater solubility and this may be attributed to 
the fact that the contact surface and cavity size of β-CD thus, 
β-CD is selected for further formulation and evaluation 
studies. 
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Fig.2:  Phase Solubility curve of Meclizine Hydrochloride 
with different concentration 
Differential scanning calorimetry 
Differential scanning calorimetry (DSC) was used to identify 
the inclusion complex between the drug and β-CD. Some 
evidence of inclusion complexation was obtained from 
thermal analysis. When guest molecules were embedded in 
β-CD cavities, their melting, boiling, or sublimation point 
generally could shift to a different temperature or disappear 
within the temperature range where β-CD was decomposed. 
As seen from Figure 3, the DSC thermogram of Meclizine HCl 
alone showed a sharp endothermic peak at 220.03 °C, 
corresponding to the melting point of the drug, while β-CD 
showed a very broad endothermic effect, which attained a 
maximum around 86.06 °C, The endothermic peaks of 
Meclizine HCl (205 °C) and β-CD (98.08 °C) observed in the 
physical mixture were significantly different from their 
endotherms in pure forms (lowering of the endothermic 
peak) indicating that complex formation has taken place only 
partially that also indicates decrease in drug crystallinity due 
to complexation. The same was the case for the complex 
prepared by a co-precipitation method where endothermic 
peaks of Meclizine HCl (185.26°C) and β-CD (99.11°C) were 
observed which indicates complex formation is not complete 
but has taken place to a greater extent. The complete 
disappearance of the Meclizine HCl endothermic peak was 
observed for the inclusion complex prepared by the 
kneading method Figure 4, since Meclizine HCl was 
contained within the cavity of the β-CD ring molecule. This 
demonstrated that an inclusion complex of Meclizine HCl 
could be obtained by the Kneading method. 
 
 
Fig 3: DSC Thermogram of Meclizine Hydrochloride 
 
Fig 4: DSC Thermogram of Meclizine Hydrochloride β CD inclusion Complex 
 
Fourier transform infrared spectroscopy 
IR spectrum of Meclizine HCl Figure 5 is characterized by 
2420cm-1 (–NH3– stretch), 2300cm-1 (CH2–CH2), 1450cm-1 (C 
= C stretch), 1080-1 (C–N stretch), 910 cm-1 (C–Cl stretch). 
The IR spectrum of pure b-CD is characterized by prominent 
peaks at 3410cm-1 (O–H), 2930.13cm-1 (C–H), 1620.73cm-
1(H–O–H bending), 1060.28cm-1 (C–O–C). No significant 
alterations in the IR bands of the pure drug were detected in 
the physical mixture. However, some of the peaks of 
Meclizine HCl were slightly shifted and found to be 
attenuated. The IR spectrum of the physical mixture could be 
diagnosed as a superimposition of the bands of pure drug 
and β-CD. Significant changes were recorded in the IR 
spectrum of the inclusion complex prepared by the kneading 
Figure 6 Almost all peaks of Meclizine HCl were smoothened 
indicating a strong physical interaction between pure drug 
and β-CD. However, the broad peak of O–H of β-CD was 
consistently appeared in binary systems. All the binary 
systems of Meclizine HCl-β-CD did not show any new peaks, 
indicating non covalent interaction in inclusion complex.
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Fig 5: Infra Red Spectrum of Drug 
 
Fig 6: Infra Red Spectrum of Drug Mix (CD) 
Scanning electron microscopy 
Fig shows the scanning electron photomicrographs of 
Meclizine Hcl, βCD and physical mixture of Meclizine Hcl β-
CD inclusion complexes prepared using the three methods. 
βCD appears to be thick solid with non-smooth surface. 
Meclizine Hcl appears to be a solid with smooth surface. The 
scanning electron photomicrographs of Meclizine Hcl β-CD 
produced from physical trituration method showed similar 
surface morphology of mixtures of Meclizine Hcl and βCD 
Figure.7. No complexation occurred between Meclizine Hcl 
and cyclodextrins using physical trituration method, 
indicating that inclusion complex could not be produced 
using physical trituration method. For kneading method, 
there was formation Meclizine Hcl / βCD complex with 
rough surface and irregular shape. 
 
20 μm
WIDTH =117.3μm
HEIGHT = 88 μmDIMENSION=1024*768*8
Meclizine Hydrochloride
LENS =1000x
DETECTOR= ROBINSON
  20 μMDIMENSION         1024*768*8
WIDTH = 117.3μm
HEIGHT =88 μm
β CYCLODEXTRIN (PURE)
LENS =1000x DETECTOR= ROBINSON
 
10 μm
DIMENSION =1024*768*8
WIDTH =46.93μm
HEIGHT =35.2 μm
LENS =2500x
INCLUSION COMPLEX
DETECTOR= ROBINSON
 
Fig-7(A) scanning electron photomicrographs of pure Meclizine Hydrochloride (B) Beta Cyclodextrins. (C) Inclusion 
Complex 
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Drug content 
The HPLC method with a UV-detector was used to determine 
the drug content of the binary system of the β-CD: Meclizine 
HCl molar ratio of 1:2, in all system samples of the binary 
system (equivalent to about 50 mg of Meclizine HCl), were 
dissolved in the mobile phase. The β-CD drug ratio would 
therefore remain 1:2] in the final solution to calculate the 
drug content. The potency content of drug in all the 
formulation was found to be 97.0 to 101.0%. 
 
 
Fig 8: chromatogram of Potency Assay 
 
In vitro dissolution studies 
The release rate profile was drawn as the cumulative percent 
release on the y-axis and time on the x-axis shown in Figure 
9. It showed that the inclusion complex (CD5) of Meclizine 
HCl prepared by the kneading method released 75.5% drug 
in 10min, and up to 98.0% drug in 45 min while the inclusion 
complex prepared by the co-precipitation method showed 
70% drug release in 10min and up to 86 % drug release in 
45 min. Physical mixtures show release up to 50% in 10 min 
and up to 70% drug release in 45 min, whereas the Market 
product exhibited the release of 81% in 10min and 97% drug 
release in 45 min. It was evident that the complex exhibited 
the faster dissolution rate than Marketed Product. The very 
high increase of Meclizine HCl dissolution rate in the case of 
inclusion complex might be due to several reasons. The 
formations of soluble inclusion complex are consequently 
solubility increase, better wettability and reduction of 
particle size. 
 
Table 2: %Cumulative drug release  
Time in 
min 
%Cumulative drug release (Avg. ± RSD; n=6) 
Innovator CD1 CD2 CD3 CD4 CD5 CD6 CD7 CD8 CD9 
0 0 0 0 0 0 0 0 0 0 0 
10 81.6±2.12 56.5±4.
65 
64.8±2.
69 
71.0±2.
41 
74.6±1.
64 
75.5±2.
07 
74.4±
2.96 
73.5±
2.51 
72.0±1.
83 
72.0±2.
91 
20 93.8±1.04 65.3±4.
53 
73.0±3.
86 
79.0±1.
32 
80.1±1.
27 
80.0±1.
50 
79.3±
1.14 
78.9±
1.90 
74.6±2.
11 
81.4±2.
56 
30 95.4±0.84 81.7±4.
15 
84.2±2.
27 
86.7±1.
62 
85.3±1.
62 
86.3±0.
76 
86.2±
1.61 
83.3±
2.05 
79.8±0.
56 
88.2±1.
35 
45 97.2±0.74 87.3±1.
35 
92.9±2.
92 
93.6±1.
59 
92.0±1.
26 
98.0 
±0.67 
92.7±
0.81 
89.9 
±0.71 
85.0±0.
57 
93.7±2.
56 
60 98.5±0.46 98.6±0.
70 
99.6±0.
69 
99.6±0.
95 
99.7±0.
57 
99.8±0.
47 
98.7±
0.63 
99.2±
0.48 
93.1±0.
71 
99.8±0.
93 
 
 
Fig 9: Dissolution comparison between RLD and different IH formulation. 
Sharma et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2019; 9(4):57-64 
ISSN: 2250-1177                                                                                  [63]                                                                                 CODEN (USA): JDDTAO 
Evaluation of precompression parameters of powder 
blend 
The angle of repose of the powder blend (CD5) was found to 
be 19.46°. The bulk density and tapped bulk density of all 
the batches were varied from 0.44 to 0.48 gm/ml and 0.60 to 
0.66 gm/ml, compressibility index of all the trial batches 
ranged from 09.182% to 11.387% and the Hausner’s ratio of 
all the batches prepared ranged from 1.106 to 1.126. 
 
Table 3:   Flow   characters   and   compressibility   of   the   prepared formulation powder blends 
Formulation 
codes 
Bulk density Tapped density Carr’s Index 
Hausner’s 
ratio 
Angle of repose 
CD1 0.45±0.00 0.65±0.00 11.045 ± 0.46 1.127 ± 0.00 21.12 ± 0.55 
CD2 0.44±0.02 0.63±0.00 11.387 ± 0.52 1.121 ± 0.01 19.32 ± 0.15 
CD3 0.47±0.00 0.64±0.01 10.632 ± 0.61 1.112 ± 0.00 24.52 ± 0.36 
CD4 0.45±0.00 0.62±0.01 11.281 ± 0.74 1.126 ± 0.01 22.35 ± 0.25 
CD5 0.48±0.01 0.62±0.01 09.812 ± 0.54 1.106 ± 0.01 19.46 ± 0.74 
CD6 0.45±0.01 0.66±0.01 11.274 ± 0.32 1.125 ± 0.01 24.12 ± 0.23 
CD7 0.44±0.00 0.62±0.00 10.097 ± 0.44 1.118 ± 0.01 23.38 ± 0.45 
CD8 0.44±0.01 0.60±0.01 09.182 ± 0.68 1.109 ± 0.01 19.28 ± 0.81 
CD9 0.42±0.00 0.71±0.00 12.112 ± 0.61 1.119 ± 0.00 22.12 ± 0.36 
 
Evaluation of postcompression parameters of tablets 
The hardness of the prepared tablet (CD5) was found to be 
10.08±0.60 kg/cm2. Friability was found to be 0.0%, which 
were below 1% indicating sufficient mechanical integrity 
and strength of prepared tablets. The disintegration time 
was found to be 02:50 to 04:02. Weight variation was found 
to be 365.0±0.92 mg which was within the permissible limit 
of ±7.5%. The in vitro dissolution studies showed that almost 
75.5% of the drug was released within 10min and almost 
98.0% of the drug was released at the end of 45min. The 
prepared tablets were compared with the marketed tablet, 
and the dissolution parameters of both formulations are 
shown in Table 4 and Figure 10. The drug content was found 
to be 99.5%. 
 
Table 4: Results of evaluation tests of Meclizine Hydrochloride tablets of all formulations 
Formulation  
code 
Hardness 
(Kg/cm
2
) 
Average Weight 
(mg) 
Disintegration time 
(minute: second) 
Friability (%) 
CD1 9.75±0.74 362.0±1.04 04:02 to 05:20 0.1 
CD2 10.30±0.79 364.0±0.62 03:25 to 04:54 0.2 
CD3 9.92±0.73 362.0±1.07 02:18 to 07:09 0.0 
CD4 9.95±0.67 363.0±1.21 01:38 to 02:30 0.0 
CD5 10.08±0.60 365.0±0.92 02:50 to 04:02 0.0 
CD6 9.87±0.69 364.0±1.26 01:48 to 02:06 0.0 
CD7 9.93±0.71 361.0±0.82 02:55 to 04:50 0.0 
CD8 9.58±0.56 359.0±1.06 03:57 to 04:49 0.0 
CD9 9.33±0.22 361.0±1.11 04:21 to 06:01 0.1 
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Fig 10: Graph Between different trials of (A) Weight variation (B) Hardness variation 
 
4.0 DISCUSSION 
From the result it is observed that the solubility of Meclizine 
HCl in the presence of β-cyclodextrin can be classified as the 
AL type. This indicated that the complexes at 1:2 ratios are 
adequately stable and also the extent of solubility 
enhancement being higher for β-CD. While the DSC 
thermogram of the kneading complex shows the complete 
disappearance of the Meclizine HCl endothermic peak and 
flattening of endotherm which indicates the formation of 
true complex and conversion of a drug-to-amorphous form. 
The dissolution rate increase for the physical mixture, 
kneaded and co-precipitation mixtures is due to the wetting 
effect of the β-CD, this effect is more evident for the kneaded 
product, where the mixing process between the two 
components is more intensive. The effect of complexation 
with β-CD on the solubility of Meclizine HCl can be explained 
in terms of the reduction in the crystallinity of the drug and 
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conversion to amorphous form by inclusion into the 
hydrophobic cavity of the β-CD.  
The FTIR spectra for Meclizine Hcl and the optimum formula 
showed the main characteristic absorption bands of 
functional groups of C-CL, C-N amine and C=C stretching . As 
shown in characteristic absorption peaks of Meclizine 
Hydrochloride appear almost at the same region. These 
results indicate that there is no chemical interaction between 
the API and the excipients and this confirms the 
compatibility of the drug with the excipients of the optimum 
formula. In vitro drug release from prepared tablets shows 
significantly improved drug dissolution as compared to the 
marketed tablet of Meclizine HCl. Hence, it could be 
concluded that the solubility enhancement of Meclizine HCl 
could be successfully achieved by the inclusion complexation 
technique and inclusion complex based fast dissolving 
tablets of Meclizine HCl would provide quick-onset of action. 
Thus, it can be summarized that stable Formulation CD5 
were prepared successfully by using Inclusion complex in 1:2 
ratio by kneading technique.  
5.0 CONCLUSIONS 
The Kneading methods could increase the solubility and 
dissolution rate of Meclizine Hydrochloride via formation of 
inclusion complex with βCD. Kneading method was the most 
effective method in terms of Meclizine Hydrochloride 
solubilization. Meclizine Hydrochloride was converted from 
crystalline to amorphous form through inclusion 
complexation. 
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